Skip to main content

Published locations for Study finds subcutaneous spesolimab reduces flares in patients with GPP

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Study finds subcutaneous spesolimab reduces flares in patients with GPP

User login

  • Reset your password
  • /content/study-finds-subcutaneous-spesolimab-reduces-flares-patients-gpp
  • /edermatologynews/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares
  • /familypracticenews/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares
  • /internalmedicinenews/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares
  • /internalmedicine/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares
  • /dermatology/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares-patients-gpp
  • /familymedicine/article/264054/psoriasis/study-finds-subcutaneous-spesolimab-reduces-flares-patients